NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,508,138 | +14.6% | 112,980 | +13.6% | 0.40% | +8.6% |
| Q2 2023 | $10,039,632 | +7.9% | 99,491 | -1.6% | 0.37% | -1.3% |
| Q1 2023 | $9,301,472 | -1.2% | 101,103 | -2.6% | 0.38% | -25.9% |
| Q4 2022 | $9,416,149 | +76.3% | 103,794 | +47.7% | 0.51% | +40.2% |
| Q3 2022 | $5,341,000 | -22.8% | 70,273 | -14.2% | 0.36% | -24.7% |
| Q2 2022 | $6,922,000 | +2.1% | 81,885 | +5.9% | 0.48% | +3.0% |
| Q1 2022 | $6,782,000 | +92.5% | 77,287 | +91.9% | 0.47% | +72.1% |
| Q4 2021 | $3,523,000 | +17.3% | 40,279 | +9.7% | 0.27% | -11.4% |
| Q3 2021 | $3,003,000 | +37.9% | 36,715 | +53.8% | 0.31% | +16.3% |
| Q2 2021 | $2,177,000 | +127.5% | 23,865 | +113.3% | 0.26% | +54.4% |
| Q1 2021 | $957,000 | +12.2% | 11,190 | +23.9% | 0.17% | -24.0% |
| Q4 2020 | $853,000 | +90.8% | 9,028 | +75.7% | 0.22% | +31.6% |
| Q3 2020 | $447,000 | -4.5% | 5,138 | -4.1% | 0.17% | -35.7% |
| Q2 2020 | $468,000 | +103.5% | 5,359 | +91.8% | 0.27% | +38.5% |
| Q1 2020 | $230,000 | – | 2,794 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |